Traws Pharma, Inc. (TRAW) Net margin 2015–2024
Traws Pharma, Inc. (TRAW) net profit margin by fiscal year — reported net income divided by reported revenue.
328.7%FY2024 · since FY2015: -354.6% → 328.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 328.7% | +74011.4 pp |
| FY2023 | -73682.7% | -65298.7 pp |
| FY2022 | -8384.1% | +7.1 pp |
| FY2021 | -8391.2% | -1239.4 pp |
| FY2020 | -7151.8% | +3738.7 pp |
| FY2019 | -10890.5% | -9905.5 pp |
| FY2018 | -985.0% | +690.3 pp |
| FY2017 | -1675.3% | +1385.9 pp |
| FY2016 | -3061.2% | -2706.6 pp |
| FY2015 | -354.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TRAW financial trends
TRAW RevenueTRAW Net incomeTRAW Gross profitTRAW Gross marginTRAW Operating incomeTRAW Operating marginTRAW Operating cash flowTRAW Free cash flowTRAW Capital expendituresTRAW Return on equityTRAW Stock buybacksTRAW Dividends paidTRAW Total assetsTRAW Total liabilitiesTRAW Shareholders’ equityTRAW overview →